electroCore, Inc. (NASDAQ:ECOR – Get Rating) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 80,500 shares, a growth of 23.1% from the February 28th total of 65,400 shares. Based on an average daily volume of 24,200 shares, the days-to-cover ratio is currently […]
electroCore, Inc. (NASDAQ:ECOR – Get Rating) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 80,500 shares, a growth of 23.1% from the February 28th total of 65,400 shares. Based on an average daily volume of 24,200 shares, the short-interest ratio is currently 3.3 days. Currently, […]
Item 2.02 Results of Operations and Financial Condition.
On November 3, 2022, electroCore, Inc. issued a press release announcing its
financial results for the quarter ended September 30, 2022. A. | November 4, 2022
ROCKAWAY, N.J., Sept. 21, 2022 electroCore, Inc. , a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark Office has issued four patents. | September 21, 2022